Candel Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $480k | 94k | 5.10 |
| 2025-06-30 | $416k | 82k | 5.06 |
| 2025-03-31 | $1.1M | 187k | 5.65 |
| 2024-12-31 | $1.4M | 157k | 8.68 |
| 2024-09-30 | $66k | 9.4k | 6.93 |
| 2024-06-30 | $37k | 6.0k | 6.20 |
| 2024-03-31 | $16 | 10 | 1.60 |
| 2023-12-31 | $18k | 12k | 1.50 |
| 2023-09-30 | $9 | 10 | 0.90 |
| 2023-06-30 | $13 | 10 | 1.30 |
| 2023-03-31 | $14 | 10 | 1.40 |
| 2022-12-31 | $1.4k | 795 | 1.80 |
| 2022-09-30 | $13k | 4.2k | 3.00 |
| 2022-06-30 | $11k | 3.8k | 3.00 |
| 2022-03-31 | $10k | 2.0k | 5.00 |
| 2021-12-31 | $35k | 4.4k | 7.75 |
| 2021-09-30 | $33k | 3.0k | 11.00 |